Clinical Trials Browser

Phase 2 × Hyperthermia, Induced × Gastrointestinal × Clear all

NCT07062055 2026-04-01

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular